News Sponsored by
GENESIS BIOSCIENCES JOINS CONSORTIUM TO TACKLE ANTIMICROBIAL RESISTANCE
Genesis Biosciences has joined the COMBAT AMR consortium which aims to understand and control the emergence and dissemination of antimicrobial resistance in complex drain biofilms.
Under the leadership of Professor Jean-Yves Maillard of Cardiff University, Genesis Biosciences will collaborate with the university and other European educational institutions on the research project.
Antimicrobial resistance is a significant global challenge and is listed on the UK government’s National Risk Register as a chronic risk that poses continuous challenges. The government’s vision is for antimicrobial resistance to be contained and controlled by 2040 and it is publishing a five-year national action plans to achieve this.
Antimicrobial resistance occurs when organisms that cause disease evolve and are no longer affected by antimicrobials including antibiotics, antifungal and antiviral medicines. It is a natural phenomenon but is rapidly accelerating due to factors including misuse or overuse of antimicrobials in humans and
NEW WIND-PROTECTIVE JACKETS AND HOODIES FROM SNICKERS WORKWEAR
Snickers Workwear’s new range of lightweight mid-layers are crafted for full flexibility on site and optimal comfort.
Built for active work, they’re fully flexible and can be worn as an outer layer when it’s warmer or a mid- layer when it’s a bit cooler.
They are full of handy technical features and innovative fabrics to tame the wind, plus brand new energising colours to brighten your spring-time workday.
Choose from new street-smart styles such as the Windblocker
14 | TOMORROW’S FM
Half-zip Hoodie or the Lightweight Flexiwork Mid-layer Jacket. There’s also a new Windproof Soft-Shell Jacket for women.
Whatever Snickers Workwear Mid- layer you choose, you can be sure that they all have body-mapping
designs for a great fit, outstanding functionality and long-lasting comfort – all day, every day.
Call: 01484 854788 Email:
sales@hultaforsgroup.co.uk www.snickersworkwear.co.uk
twitter.com/TomorrowsFM
animals, environmental contamination and poor infection control practices.
Biofilms, communities of microorganisms living on surfaces, are the most common mode of bacterial growth and harbour pathogens, particularly antimicrobial and multidrug resistant pathogens. Due to their ubiquitous nature, biofilms are recognised as a major cause of antimicrobial resistance.
The COMBAT AMR consortium is studying drain biofilms from farms, healthcare settings and homes to understand the complexity of biofilms in different environments and the persistence of antimicrobial genes and multidrug resistant organisms within those biofilms.
The consortium is using a new multi-species biofilm model based on research by Dr Kate Ledwoch, Laboratory Manager at Genesis Biosciences, and fellow scientists which was published in the Journal of Hospital Infection in 2020.
The innovative model will be used during the project to measure the efficacy of several interventions to control the biofilms, explore the
maximum eco
phenotypic characterisations of the key pathogens and establish an impact intervention to control antimicrobial resistant organisms on their resistance genes within the biofilms.
Dr Emma Saunders, General Manager at Genesis Biosciences, said: “Antimicrobial resistance is a threat to both human and animal health, impacting the ability to treat infections and ensure food security. As biofilms act as a reservoir for harmful, resistant pathogens, it is important to improve our understanding of antimicrobial genes and the impact of disinfection on complex biofilms. We are looking forward to working with Cardiff University and the other members of the consortium to help tackle this global challenge.”
www.genesisbiosciences.co.uk
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70